PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $401,724 | -22.3% | 13,094 | +1.4% | 0.00% | -25.0% |
Q2 2023 | $517,183 | -4.7% | 12,907 | -2.9% | 0.00% | -20.0% |
Q1 2023 | $542,528 | +8.7% | 13,294 | +2.8% | 0.01% | 0.0% |
Q4 2022 | $499,227 | -24.0% | 12,930 | +4.7% | 0.01% | -28.6% |
Q3 2022 | $657,000 | -6.7% | 12,347 | +2.3% | 0.01% | 0.0% |
Q2 2022 | $704,000 | -23.4% | 12,072 | +0.3% | 0.01% | 0.0% |
Q1 2022 | $919,000 | +27.6% | 12,041 | +0.6% | 0.01% | +40.0% |
Q4 2021 | $720,000 | +7.1% | 11,965 | -0.2% | 0.01% | 0.0% |
Q3 2021 | $672,000 | -6.3% | 11,992 | +1.5% | 0.01% | -16.7% |
Q2 2021 | $717,000 | -14.8% | 11,809 | -1.7% | 0.01% | -14.3% |
Q1 2021 | $842,000 | +19.4% | 12,014 | +2.0% | 0.01% | +16.7% |
Q4 2020 | $705,000 | -2.9% | 11,776 | -2.5% | 0.01% | -14.3% |
Q3 2020 | $726,000 | +53.5% | 12,074 | +34.0% | 0.01% | 0.0% |
Q2 2020 | $473,000 | +59.8% | 9,013 | +2.2% | 0.01% | +40.0% |
Q1 2020 | $296,000 | -76.5% | 8,817 | -68.3% | 0.01% | -66.7% |
Q4 2019 | $1,261,000 | -32.0% | 27,828 | -42.9% | 0.02% | -34.8% |
Q3 2019 | $1,854,000 | – | 48,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |